Supplementary Figure 3 from Intravenous Injection of MVA Virus Targets CD8+ Lymphocytes to Tumors to Control Tumor Growth upon Combinatorial Treatment with a TLR9 Agonist

Authors :: Xavier Préville
Sylvie Fournel
Sandrine Cochin
Karola Rittner
Emmanuelle Schaedler
Murielle Gantzer
Jacqueline Kintz
Tanja Gatard-Scheikl
Laetitia Fend
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figure 3. Percentages of splenic and tumor infiltrating T lymphocytes expressing CCR1, CCR2, CCR3 or CCR5.

Full Text Access

Tools